Association of blood lipids and albumin-bilirubin index with disease progression in patients with chronic hepatitis B virus infection

Cao WenJun; Wang TongTong; Gao YuFeng; Zou GuiZhou

doi:10.3969/j.issn.1001-5256.2019.03.014

Volume 35 Issue 3

Mar. 2019

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2019 > 35(3): 522-525

PDF( 2036 KB)

Association of blood lipids and albumin-bilirubin index with disease progression in patients with chronic hepatitis B virus infection

DOI: 10.3969/j.issn.1001-5256.2019.03.014

Department of Hepatology, The Second Affiliated Hospital of Anhui Medical University

Research funding:

Received Date: 2018-10-09
Published Date: 2019-03-20

Abstract

Abstract

Objective To investigate the value of blood lipid indices and albumin-bilirubin index ( ALBI) in evaluating the progression ofchronic hepatitis B virus ( HBV) infection. Methods A total of 184 patients with chronic HBV infection who visited The Second AffiliatedHospital of Anhui Medical University from June 2016 to June 2017 were enrolled, and according to the stage of the disease, they were divid-ed into ASC group ( 74 HBV carriers) , CHB group ( 70 patients with chronic hepatitis B) , and LC group ( 40 patients with compensated cir-rhosis) . A total of 50 healthy individuals were enrolled as health control ( HC) group. Blood lipid indices and liver function parameters weremeasured, and the changes in blood lipid indices and ALBI during the progression of chronic HBV infection were analyzed. A one-way a-nalysis of variance was used for comparison of continuous data between multiple groups, and the Dunnett method was used for further compar-ison between two groups; the chi-square test was used for comparison of categorical data between groups; Pearson correlation analysis wasused to investigate correlation. Results There were significant differences between the ASC, CHB, LC, and HC groups in blood lipid indi-ces of cholesterol ( CHO) , high-density lipoprotein cholesterol ( HDL-C) , low-density lipoprotein cholesterol ( LDL-C) , apolipopro-tein A ( APOA) , and apolipoprotein B ( F = 12. 075, 19. 559, 6. 554, 9. 392, and 5. 458, all P < 0. 001) , and the LC group had signifi-cantly greater reductions in the above indices compared with the other three groups ( all P < 0. 05) . There was a significant difference in AL-BI between the four groups ( F = 49. 225, P < 0. 001) ; the LC group had a significantly higher ALBI than the other three groups ( all P <0. 05) , and the ASC and CHB groups had a significantly higher ALBI than the HC group ( both P < 0. 05) . CHO, HDL-C, LDL-C, andAPOA were negatively correlated with ALBI ( all P < 0. 05) , among which CHO and HDL-C had the strongest correlation with ALBI ( r =-0. 310 and-0. 266, both P < 0. 001) . Conclusion In patients with chronic HBV infection, blood lipid indices and ALBI can reflectthe degree of liver function damage, especially in patients with liver cirrhosis.
- hepatitis B virus,
- dyslipidemias,
- apolipoproteins,
- albumin-bilirubin index,
- hepatic insufficiency

FullText(HTML)

References(15)

References

[1] YANG S, LIN Q, LIN W, et al. Effect of adjuvant interferontherapy on hepatitis B virus-related hepatocellular carcino-ma:A systematic review[J]. World J Surg Oncol, 2016, 14 (1) :159.

[2] SHI J, SHEN Z, MIAO H, et al. Association between serumlipid levels and antiviral treatment outcome inpatients with chro-nic hepatitis[J]. J Clin Hepatol, 2014, 30 (6) :496-500. (inChinese) 时佳, 沈震, 苗慧, 等.血脂水平与慢性丙型肝炎患者抗病毒疗效的相关性分析[J].临床肝胆病杂志, 2014, 30 (6) :496-500.

[3] ABBASI A, BHUTTO AR, BUTT N, et al. Serum cholesterol:Could it be a sixth parameter of Child-Pugh scoring system incirrhotics due to viral hepatitis?[J]. J Coll Physicians SurgPak, 2012, 22 (8) :484-487.

[4] WANG CC, TSENG TC, KAO JH. Hepatitis B virus infectionand metabolic syndrome:Fact or fiction?[J]. J Gastroen-terol Hepatol, 2015, 30 (1) :14-20.

[5] NAU AL, SOARES JC, SHIOZAWA MB, et al. Clinical and la-boratory characteristics associated with dyslipidemia and liversteatosis in chronic HBV carriers[J]. Rev Soc Bras Med Trop, 2014, 47 (2) :158-164.

[6] JOHNSON PJ, BERHANE S, KAGEBAYASHI C, et al. As-sessment of liver function in patients with hepatocellular carci-noma:A new evidence-based approach-the ALBI grade[J]. J Clin Oncol, 2015, 33 (6) :550-558.

[7] BO C, SHA L. Albumin-bilirubin (ALBI) score at admissionpredicts possible outcomes in patients with acute-on-chron-ic liver failure[J]. Medicine, 2017, 96 (24) :e7142.

[8] Chinese Society of Hepatology and Chinese Society of Infec-tious Diseases, Chinese Medical Association. The guidelinesof prevention and treatment for chronic hepatitis B:A 2015 Up-date[J]. J Clin Hepatol, 2015, 31 (12) :1941-1960. (inChinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2015年更新版) [J].临床肝胆病杂志, 2015, 31 (12) :1941-1960.

[9] ZHANG C, GONG L, CHEN Y, et al. A human-derived pro-tein SBP (HBsAg-binding protein) can bind to hepatitis B vi-rus surface antigen (HBs Ag) and enhance the immune re-sponse to hepatitis B virus (HBV) vaccine[J]. Mol Immunol, 2013, 53 (1-2) :60-71.

[10] VERE CC, NEAGOE D, STREBA CT, et al. Steatosis and ser-um lipid patterns in patients with chronic viral hepatitis:Differ-ences related to viral etiology[J]. Rom J Morphol Embryol, 2010, 51 (3) :509-514.

[11] ARAIN SQ, TALPUR FN, CHANNA NA, et al. Serum lipids asan indicator for the alteration of liver function in patients withhepatitis B[J]. Lipids Health Dis, 2018, 17 (1) :36.

[12] WU T, ZHENG X, YANG M, et al. Serum lipid alterations iden-tified in chronic hepatitis B, hepatitis B virus-associated cir-rhosis and carcinoma patients[J]. Sci Rep, 2017, 7:42710.

[13] GHADIR MR, RIAHIN AA, HAVASPOUR A, et al. The relation-ship between lipid profile and severity of liver damage in cir-rhotic patients[J]. Hepat Mon, 2010, 10 (4) :285-288.

[14] BASSANI L, FERNANDES SA, RAIMUNDO FV, et al. Lipidprofile of cirrhotic patients and its association with prognosticscores:A cross-sectional study[J]. Arq Gastroenterol, 2015, 52 (3) :210.

[15] CHEN RC, CAI YJ, WU JM, et al. Usefulness of albumin-biliru-bin grade for evaluation of long-term prognosis for hepatitis B-related cirrhosis[J]. J Viral Hepat, 2017, 24 (13) :238-245.

Relative Articles

[1]	Tong LIU, Shanzheng LI, Cheng ZHOU, Sutong LIU, Lihui ZHANG, Wenxia ZHAO. Study on the protective efect and mechanism of paeoniflorin on palmitic acid-induced HepG2 cells[J]. Journal of Clinical Hepatology, 2025, 41(3): 499-505. doi: 10.12449/JCH250316
[2]	Lai Xin, Zhou TaiCheng, Wei Jia. Association between HBV A1762T/G1764A double nucleotide substitution and liver diseases[J]. Journal of Clinical Hepatology, 2018, 34(9): 1990-1994. doi: 10.3969/j.issn.1001-5256.2018.09.034
[3]	Pang Ting, Xing HuiChun. Correlation between drug-resistance gene mutations and hepatocellular carcinoma in patients with hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2017, 33(1): 82-86. doi: 10.3969/j.issn.1001-5256.2017.01.017
[4]	Du SenRong, Mao XiaoRong, Xiao Ping, Chen Hong. Effects of PARP-1 inhibitors AG-014699 and AZD2281 on proliferation and apoptosis of human hepatoma cell line HepG2[J]. Journal of Clinical Hepatology, 2015, 31(6): 943-946. doi: 10.3969/j.issn.1001-5256.2015.06.027
[5]	Wang LiPing, Han FangZheng, Li ChunYang, Yan Mei, Zhang YanChao, Yan XueBing. Evaluation of adefovir primary resistance and adefovir repulsive mutations of the HBV DNA P gene in chronic hepatitis B patients[J]. Journal of Clinical Hepatology, 2012, 28(8): 606-608.
[6]	Jin WenWen, Xin YongNing, Dong QuanJiang, Zhao ShouFeng, Yu XinJuan, Jiang Man, Xu Jing, Xuan ShiYing. The preliminary study on the relationship between hepatitis B virus BCP gene mutations and HBV-related primary hepatocellular carcinoma in Qingdao[J]. Journal of Clinical Hepatology, 2012, 28(2): 130-134.
[7]	Yang YanLin, Xiao Ping, Gao Peng, Wang LiMing, Wei XiSheng, He Qiang, Zhou Ping. Distribution of HBV genotypes and YMDD mutations in E antigen-positive patients[J]. Journal of Clinical Hepatology, 2012, 28(6): 428-430.
[8]	Hong YuBo, Zhang Ting, Sun LiGuang. Association between IL-2 +114 (G/T) polymorphism and susceptibility to hepatitis B, cirrhosis, and hepatocellular carcinoma in Jilin province[J]. Journal of Clinical Hepatology, 2012, 28(12): 930-933.
[9]	Deng Le, Wen ZhiLi. Review of recent research progress in correlating HBV genotypes with efficacy of antiviral treatments[J]. Journal of Clinical Hepatology, 2012, 28(6): 469-473.
[10]	Zhang JianJun, Wu LiPing, Du RuiQing, Wang JianBin, Yao ZhanCheng, Yu GuiQin. Factors correlating with the liver inflammation grade ≥G2 in chronic HBV-infected patients with normal liver function[J]. Journal of Clinical Hepatology, 2012, 28(1): 35-38.
[11]	Liu JinPing, Liu YouDe, Guo YanMei, Yang ShaoPing, Lin Qing, Lin Ling. Clinical characteristics and distribution of hepatitis B virus genotypes in CHB patients in Yantai area[J]. Journal of Clinical Hepatology, 2011, 27(12): 1288-1290.
[12]	Zou XiaoJing, Jiang XueQiang, Tian DeYing. Role of DC-SIGN on the maturation and activation of dendritic cells in chronic hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2011, 27(2): 145-147+153.
[13]	Xiong QiXiang, Xiong LiJuan. Hepatitis B virus infection and DNA methylation in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2011, 27(8): 881-884.
[14]	Pan Lei, Wei Xin, Xie YuMei, Hao ChunQiu, Wang JiuPing, Jia ZhanSheng, Bai XueFan. Anti-viral therapy with pegylated interferon alpha-2a plus ribavirin in patients co-infected with HBV and HCV[J]. Journal of Clinical Hepatology, 2011, 27(1): 84-85+95.
[15]	Yuan JianGuo, Wang XinGuo, Cui Xia, Liu FengHua, Wang FengHua, Song JiKui, Zhao HongKui. The activation of rat hepatic stellate cells stimulated with hepatitis B virus in vitro[J]. Journal of Clinical Hepatology, 2011, 27(2): 163-165.
[16]	Xi HongLi, Liu FangFang, Yuan JiaYing, Yu YanYan. Significance and detection of IL-2、IL-4 and IFN-γ in PBMC from patients with hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2010, 26(6): 627-629.
[17]	Wang GuoQiang, Niu JuXia. The HBx protein mutation among different HBV genotypes[J]. Journal of Clinical Hepatology, 2010, 26(4): 392-394.
[18]	Shi YanMei, Lan YingHua, Dan Lei, Zhou Jin, Li YongGuo. The relationship between of hematopoietic stem cells and hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2010, 26(4): 377-380.
[19]	Xie DeSheng, Zhang QingBo, Chen ChangXing, Huang JianFang, Ma Jin, Huang HaiBin, Du Yao. The relationship between HBV gene mutation in HBV infected family and HLA class Ⅱ alleles[J]. Journal of Clinical Hepatology, 2010, 26(4): 383-386.
[20]	Xu ZhengJu, Yang Hong, Zhang QiHua, Chen XianLi, Li ShuQing, Wang ChongGuo. Study on the relationship between hepatitis B virus genotypes and effect of lamivudine therapy.[J]. Journal of Clinical Hepatology, 2005, 21(3): 157-159.

Supplements(0)

Cited By

Cited by

Periodical cited type(2)

1.	中国抗癌协会肿瘤消融治疗专业委员会，中国临床肿瘤学会肿瘤消融治疗专家委员会，中国医师协会介入医师分会介入围手术学组. 复合式冷热消融治疗肝肿瘤围手术期管理专家共识. 中华内科杂志. 2025(02): 110-118 .
2.	温钊，臧铁柱，宋晓改，张炫，江艳丽. 射频消融治疗包膜下与非包膜下早期肝细胞癌患者的远期预后. 河南医学研究. 2023(15): 2738-2744 .

Other cited types(0)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (1423) PDF downloads(320)

Association of blood lipids and albumin-bilirubin index with disease progression in patients with chronic hepatitis B virus infection

DOI: 10.3969/j.issn.1001-5256.2019.03.014